Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis
Joan Perelló(Sanifit (Spain)), Carolina Salcedo(Sanifit (Spain)), Bernat Isern(Sanifit (Spain)), Miguel D. Ferrer(Health Research Institute of the Balearic Islands), Geert J. Behets(University of Antwerp), Vincent M. Brandenburg(Klinikum Rheine), Nadine Kaesler(RWTH Aachen University), María del Mar Pérez Gómez(Sanifit (Spain)), Patrick C. D’Haese(University of Antwerp), Rekha Garg(Therapeutics Clinical Research), Alex Gold(Portola Pharmaceuticals (United States)), Myles Wolf(Harvard University)
Cited by 48
Related Papers
Common genetic determinants of vitamin D insufficiency: a genome-wide association study
|The Lancet|2010|1.5k
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
|New England Journal of Medicine|2015|1k
Vitamin D levels and early mortality among incident hemodialysis patients
|Kidney International|2007|791
Activated Injectable Vitamin D and Hemodialysis Survival
|Journal of the American Society of Nephrology|2005|784
Spatial multi-omic map of human myocardial infarction
|Nature|2022|675